Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Gerges (Wien, Austria), R. Friewald (Wien, Austria), I. Shafran (Wien, Austria), R. Sadushi-Kolici (Wien, Austria), N. Skoro-Sajer (Wien, Austria), M. Gerges (Wien, Austria), B. Moser (Wien, Austria), S. Taghavi (Wien, Austria), W. Klepetko (Wien, Austria), I. Lang (Wien, Austria). BPA for CTEPH: the Viennese experience. 1547

Member's Comments

No comment yet.

Related content which might interest you: Psychological differences between people with PAH, IPAH and CTEPH Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016 Building a pulmonary thromboendarterectomy program in Turkey: Early experience and preliminary results Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders Year: 2010 Macitentan in chronic thromboembolic pulmonary hypertension (CTEPH): experience from the OPUS registry Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension Year: 2018 The management and follow-up of pulmonary embolism (PE) at a district general hospital: Are we missing CTEPH? Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013 Modern management of portopulmonary hypertension in children : case series of an expert center Source: International Congress 2017 – PAH and CTEPH Year: 2017 Selexipag real-world experience in patients over 75 yrs with pulmonary arterial hypertension (PAH) Source: Virtual Congress 2021 – Therapy of pulmonary hypertension Year: 2021 Macitentan for pulmonary arterial hypertension (PAH): Early clinical experience of 94 patients Source: International Congress 2015 – Pulmonary hypertension: management Year: 2015 My experience of pulmonary rehabilitation: a patient perspective Source: International Congress 2019 – Effects of pulmonary rehabilitation other than improving exercise capacity Year: 2019 Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry Source: ERJ Open Res, 7 (3) 00850-2020; 10.1183/23120541.00850-2020 Year: 2021 Wood smoke exposure as a risk factor for obstructive pulmonary disease in women: the Barcelona study Source: Eur Respir J 2004; 24: Suppl. 48, 2s Year: 2004 Pulmonary thromboembolic disease – an observational study in internal medicine department Source: Eur Respir J 2007; 30: Suppl. 51, 81s Year: 2007 Determinants of diagnostic delay in chronic thromboembolic pulmonary hypertension: results from the European CTEPH Registry Source: Eur Respir J, 52 (6) 1801687; 10.1183/13993003.01687-2018 Year: 2018 Managing pregnancy in pulmonary hypertension using a multi-professional approach: a 16-year experience in a specialist referral centre Source: International Congress 2017 – PAH and CTEPH Year: 2017 Pulmonary veno-occlusive disease (PVOD) induced by chemotherapy: Experience from the French PH network and literature review Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Late Breaking Abstract - Occupational exposure to disinfectants and COPD incidence in US nurses: a prospective cohort study Source: International Congress 2017 – The air indoor air pollution Year: 2017 Pulmonary thromboembolism in childhood: Six years of single center experience Source: Virtual Congress 2020 – Pulmonary embolism Year: 2020 The obesity paradox in pulmonary arterial hypertension: the Scottish perspective Source: ERJ Open Res, 5 (4) 00241-2019; 10.1183/23120541.00241-2019 Year: 2019